K221-3482 Screening compound: 3-[2-(3,4-dimethoxyphenyl)ethyl]-7-[4-(pyridin-2-yl)piperazine-1-carbonyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione

K221-3482 Screening compound: 3-[2-(3,4-dimethoxyphenyl)ethyl]-7-[4-(pyridin-2-yl)piperazine-1-carbonyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione
K221-3482 Screening compound: 3-[2-(3,4-dimethoxyphenyl)ethyl]-7-[4-(pyridin-2-yl)piperazine-1-carbonyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione alternative view

Chemical Structure Depiction of ChemDiv screening compound K221-3482
3-[2-(3,4-dimethoxyphenyl)ethyl]-7-[4-(pyridin-2-yl)piperazine-1-carbonyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

K221-3482

Molecular Formula

C28H29N5O5 (C28 H29 N5 O5)

Compound Name

3-[2-(3,4-dimethoxyphenyl)ethyl]-7-[4-(pyridin-2-yl)piperazine-1-carbonyl]-1,2,3,4-tetrahydroquinazoline-2,4-dione

IUPAC name

3-[2-(34-dimethoxyphenyl)ethyl]-7-[4-(pyridin-2-yl)piperazine-1-carbonyl]-1234-tetrahydroquinazoline-24-dione

SMILES

COc(ccc(CCN(C(c(ccc(C(N(CC1)CCN1c1ncccc1)=O)c1)c1N1)=O)C1=O)c1)c1OC

InChI

InChI=1S/C28H29N5O5/c1-37-23-9-6-19(17-24(23)38-2)10-12-33-27(35)21-8-7-20(18-22(21)30-28(33)36)26(34)32-15-13-31(14-16-32)25-5-3-4-11-29-25/h3-9,11,17-18H,10,12-16H2,1-2H3,(H,30,36)

InChI Key

VLBDYKQXPJZPNL-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15082386

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

515.57

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

2.960

Distribution Coefficient, logD

2.950

Water Solubility, LogSw

-3.43

Polar Surface Area

84.139

Acid Dissociation Constant (pKa)

10.00

Base Dissociation Constant (pKb)

5.71

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.60

K221-3482 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Angiogenesis library (14822 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Epigenetics Focused Set (26518 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Cancer

References: we are preparing a list of scientific research reports with K221-3482 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound K221-3482?
Check Price and Availability of K221-3482, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of K221-3482 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for K221-3482
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for K221-3482
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of K221-3482 available by request